Management of suspected myocardial infarction before admission: Updated audit

British Medical Journal

Volumn 316, Issue 7128, 1998, Pages 353-

  Prasad, N ^a   Srikanthan, V S ^a   Wright, A ^a   Dunn, F G ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CREATINE KINASE; FIBRINOLYTIC AGENT; OPIATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; FEMALE; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; THORAX PAIN; TIME;

EID: 6844239552     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7128.353     Document Type: Article

References (4)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction. Lancet 1988;ii:319-60.
2. British Heart Foundation Working Group. Role of the general practitioner in managing patients with myocardial infarction: impact of thrombolytic treatment BMJ 1989:299:555-7.
3. Wyllie IIR, Dunn FG. Pre-hospital opiate and aspirin administration in patients with suspected myocardial infarction. BMJ 1994;308:760-1.
4. Burns JMA, Hogg KJ, Rae AP, Hillis WS, Dunn FG. Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Dr HeartJ 1989;61322-5.